Stereotactic Image-Guided Neoadjuvant Ablative Radiation Then Lumpectomy

NAActive, not recruitingINTERVENTIONAL
Enrollment

139

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

April 30, 2021

Study Completion Date

April 30, 2024

Conditions
Early Stage Breast Carcinoma
Interventions
RADIATION

Stereotactic Body Radiation Then Surgery

Stereotactic image-guided neoadjuvant ablative radiation (randomized to single dose of 21 Gy or three 10 Gy doses) followed by lumpectomy for early stage breast carcinoma

Trial Locations (1)

N6A 4L6

London Regional Cancer Program of the Lawson Health Research Institute, London

Sponsors
All Listed Sponsors
collaborator

Weill Medical College of Cornell University

OTHER

collaborator

Sunnybrook Health Sciences Centre

OTHER

collaborator

Ontario Institute for Cancer Research

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER